Healthcare & life sciences

Future health

How the industry will move from “one size fits all” to “ultra-targeted” care

Maximizing the rare chance of launch success with orphan drugs

A strategic approach to achieving launch excellence and success for rare-disease medicines

10 %
Share of healthcare industry in global GDP
480 B$
Estimated value of the global biologics market in 2024 (billion USD)
20 %
Year-on-year growth rate of investments in digitalization of the healthcare sector
Challenges

The healthcare industry is increasingly becoming resource constrained. A new generation of products and technological advances are making it challenging for companies to seek out the right investment opportunities for their businesses –...

Services

At Arthur D. Little, we help clients realize the full value of their medical innovations by leveraging our team’s talent and industry expertise in a way that challenges traditional thinking but leads to solutions that are competitive and...

Results

We work side-by-side with our clients from biotech, healthtech, medtech, diagnostics/medical device, and pharmaceutical companies, as well as private and public healthcare payers and providers (hospitals and hospital systems, primary-care organizations, insurance providers, counties and regional-care organizations). We help them build adequate innovative solutions and make change happen.